DE69606566D1 - Pharmazeutische Benzofuranverbindungen - Google Patents

Pharmazeutische Benzofuranverbindungen

Info

Publication number
DE69606566D1
DE69606566D1 DE69606566T DE69606566T DE69606566D1 DE 69606566 D1 DE69606566 D1 DE 69606566D1 DE 69606566 T DE69606566 T DE 69606566T DE 69606566 T DE69606566 T DE 69606566T DE 69606566 D1 DE69606566 D1 DE 69606566D1
Authority
DE
Germany
Prior art keywords
alkyl
pharmaceutical
benzofuran compounds
dimethylpyrrolidino
chr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69606566T
Other languages
English (en)
Other versions
DE69606566T2 (de
Inventor
Henry Uhlman Bryant
Jeffrey Alan Dodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69606566D1 publication Critical patent/DE69606566D1/de
Publication of DE69606566T2 publication Critical patent/DE69606566T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69606566T 1995-03-10 1996-03-06 Pharmazeutische Benzofuranverbindungen Expired - Fee Related DE69606566T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/402,285 US5523309A (en) 1995-03-10 1995-03-10 Benzofuran pharmaceutical compounds

Publications (2)

Publication Number Publication Date
DE69606566D1 true DE69606566D1 (de) 2000-03-16
DE69606566T2 DE69606566T2 (de) 2000-06-29

Family

ID=23591296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606566T Expired - Fee Related DE69606566T2 (de) 1995-03-10 1996-03-06 Pharmazeutische Benzofuranverbindungen

Country Status (15)

Country Link
US (1) US5523309A (de)
EP (1) EP0731097B1 (de)
JP (1) JP2000510814A (de)
AT (1) ATE189678T1 (de)
AU (1) AU692690B2 (de)
BR (1) BR9607774A (de)
CA (1) CA2214450A1 (de)
DE (1) DE69606566T2 (de)
DK (1) DK0731097T3 (de)
ES (1) ES2142021T3 (de)
GR (1) GR3033326T3 (de)
IL (1) IL117396A (de)
PT (1) PT731097E (de)
WO (1) WO1996028152A1 (de)
ZA (1) ZA961882B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703407B1 (en) * 1994-09-20 2004-03-09 Eli Lilly And Company Benzofuran compounds, compositions, and methods
US6417199B1 (en) * 1995-03-10 2002-07-09 Eli Lilly And Company 3-benzyl-benzothiophenes
US6653328B1 (en) * 1995-03-10 2003-11-25 Eli Lilly And Company 3-benzyl-benzothiophenes
US6395755B1 (en) * 1995-03-10 2002-05-28 Eli Lilly And Company Benzothiophene pharmaceutical compounds
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
US5567828A (en) * 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
WO1997025033A1 (en) 1995-10-31 1997-07-17 Eli Lilly And Company Antithrombotic diamines
CA2214919A1 (en) * 1996-09-24 1998-03-24 Kenneth Lee Hauser Benzothiophene compounds, intermediates, processes, compositions, and methods
US5990169A (en) * 1996-10-23 1999-11-23 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6153631A (en) * 1996-10-23 2000-11-28 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US5922753A (en) * 1996-10-23 1999-07-13 Zymogenetics, Inc. Methods for treating bone deficit conditions with benzothiazole
US6017940A (en) * 1996-10-23 2000-01-25 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US5948776A (en) * 1996-10-23 1999-09-07 Zymogenetic, Inc. Compositions and methods for treating bone deficit conditions
US5965573A (en) * 1996-10-23 1999-10-12 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6251901B1 (en) 1996-10-23 2001-06-26 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6342514B1 (en) 1996-10-23 2002-01-29 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US5939444A (en) * 1996-10-23 1999-08-17 Zymogenetic, Inc. Compositions and methods for treating bone deficit conditions
EP0973513A4 (de) * 1996-10-23 2003-03-19 Zymogenetics Inc Zusammenstellungen und verfahren zur behandlung von knochenmangelerscheinungen
US5919808A (en) * 1996-10-23 1999-07-06 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
EP0973517A4 (de) 1997-04-30 2002-07-24 Lilly Co Eli Antithrombotische mittel
CA2287982A1 (en) 1997-04-30 1998-11-05 Michael Enrico Richett Antithrombotic agents
CA2287993A1 (en) 1997-04-30 1998-11-05 Mary George Johnson Antithrombotic agents
DE69828522T2 (de) 1997-04-30 2005-12-15 Eli Lilly And Co., Indianapolis Antithrombotische mittel
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US6649631B1 (en) 1997-10-23 2003-11-18 The Board Of Regents Of The University Of Texas System Compositions and methods for treating bone deficit conditions
US6284756B1 (en) 1998-04-30 2001-09-04 Eli Lilly And Company Antithrombotic agents
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ES2189355T3 (es) * 1998-10-28 2003-07-01 Lilly Co Eli Compuestos de benzotiofeno como agentes antitromboticos e intermedios.
FR2813306B1 (fr) * 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
FR2813307B1 (fr) * 2000-08-23 2002-11-08 Sanofi Synthelabo Aminoalkenylbenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
US20040034049A1 (en) * 2000-10-05 2004-02-19 Shigenori Okawa Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
WO2002094788A1 (en) * 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
WO2002094268A1 (en) * 2001-05-22 2002-11-28 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
EP1631561B1 (de) * 2003-05-07 2010-08-18 General Electric Company Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
US7420066B2 (en) 2003-08-07 2008-09-02 Bayer Pharmaceuticals Corporation Benzofuran derivatives useful for treating hyper-proliferative disorders
CN114315774B (zh) * 2022-01-04 2023-05-09 山东第一医科大学(山东省医学科学院) Psf蛋白抑制剂、药物组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5354861A (en) * 1992-11-04 1994-10-11 National University Of Singapore 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes

Also Published As

Publication number Publication date
EP0731097A1 (de) 1996-09-11
JP2000510814A (ja) 2000-08-22
ES2142021T3 (es) 2000-04-01
IL117396A0 (en) 1996-07-23
AU5187396A (en) 1996-10-02
WO1996028152A1 (en) 1996-09-19
EP0731097B1 (de) 2000-02-09
DE69606566T2 (de) 2000-06-29
AU692690B2 (en) 1998-06-11
CA2214450A1 (en) 1996-09-19
MX9706738A (es) 1997-11-29
GR3033326T3 (en) 2000-09-29
US5523309A (en) 1996-06-04
PT731097E (pt) 2000-07-31
ATE189678T1 (de) 2000-02-15
IL117396A (en) 2000-01-31
DK0731097T3 (da) 2000-05-15
ZA961882B (en) 1997-09-08
BR9607774A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
ATE189678T1 (de) Pharmazeutische benzofuranverbindungen
BR9305182A (pt) Composto e formulação farmaceûtica
LU92545I2 (fr) Ezetimibe en combinaison avec atorvastatine ou leurs sels pharmaceutiquement acceptées, y compris atorvastatine sous forme d'atorvastatine calcique trihydratée
MX9603508A (es) Analogos de la doxiciclina.
DE69720551D1 (de) Makrozyklische derivate von erythromycin a und b mit 13 ringatomen
TR199700178A2 (tr) Tümörlerin ve iltihapli hastaliklarin tedavisine yönelik yeni pro ilaclar.
YU4198A (sh) Karbapenem antibiotik, kompozicija i postupak za dobijanje
ES2069100T3 (es) Inmunosupresor y procedimiento para la produccion del mismo.
FI865320A0 (fi) Antibiotiska a 40926 n-acylaminoglukuronyl -aglykoner och antibiotisk a 40926 aglykon.
DE3856387D1 (de) 1,2,3,4,10,14b-HEXAHYDRODIBENZO-c,f]PYRAZINO-1,2-a]AZEPINO-DERIVATE
CA2071669A1 (en) Aminophenoxyalkyl derivatives of benzodioxan
DE69803894D1 (de) Heterozyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DK0461574T3 (da) Lægemidler indeholdende 3,7-diazabicyclo(3,3,1)-nonanforbindelser
ATE62244T1 (de) Pyrrolo(1,2-a>(4,1>benzoxazepine, verfahren zur ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie therapeutische verwendung.
DE59712053D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
KR910000785A (ko) 9-r-아자사이클릭 에리트로마이신 항생제
ATA137591A (de) Verwendung eines antibiotikums des typs 2-desoxystreptamin
FI922880A0 (fi) Antipsykotiska benzodioxanderivat.
ES2063328T3 (es) Nuevo uso de naftoxazinas.
PT84328A (en) Heterocyclic compounds and their preparation and pharmaceutical formulation
IT1204458B (it) Derivati eterociclici
IT1201455B (it) Derivati piridinici sostituiti
ATE44032T1 (de) Pyrrolo(1,2-a>azepinonderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
HUT48873A (en) Process for producing dihydropyridine derivatives and pharmaceutical compositions comprising these compounds as active ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee